Cargando…
Association of Cognitive Impairment in Patients on 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitors
BACKGROUND: Atherosclerotic cardiovascular diseases are the leading cause of death in the United States. A reduction in cholesterol with 3-hydroxy-3-methyl-glutaryl-CoA reductase inhibitors (statin) significantly reduces mortality and morbidity. Statins may be associated with cognitive impairment or...
Autores principales: | Roy, Satyajeet, Weinstock, Joshua Louis, Ishino, Allyse Sachiko, Benites, Jefferson Felix, Pop, Samantha Rachel, Perez, Christopher David, Gumbs, Edvard Adrian, Rosenbaum, Jennifer Ann, Roccato, Mary Kate, Shah, Hely, Contino, Gabriela, Hunter, Krystal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458663/ https://www.ncbi.nlm.nih.gov/pubmed/28611866 http://dx.doi.org/10.14740/jocmr3066w |
Ejemplares similares
-
The pleiotropic effects of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in renal disease
por: Gomez, Sabas I, et al.
Publicado: (2014) -
In silico investigation on alkaloids of Rauwolfia serpentina as potential inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase
por: Azmi, Muhammad Bilal, et al.
Publicado: (2021) -
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
por: Drouot, Laurent, et al.
Publicado: (2014) -
In Vitro Evaluation of Farnesyltransferase Inhibitor and its Effect in Combination with 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor against Naegleria fowleri
por: Hahn, Hye Jee, et al.
Publicado: (2020) -
Effect of Concomitant 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Therapy on Creatine Phosphokinase Levels and Mortality Among Patients Receiving Daptomycin: Retrospective Cohort Study
por: McConnell, Heather L., et al.
Publicado: (2014)